Social Media Ideas for Biocon Limited Latest News

Pharma Stock Jumps After Securing ₹515 Cr Contracts from Malaysia’s Ministry of Health

Synopsis: Biocon strengthened its Malaysia presence after partner Duopharma secured insulin contracts worth over ₹514 crore, supporting affordable diabetes treatment and expanding...

Biocon slips despite BBL turning wholly-owned subsidiary

On Monday, Biocon completed the acquisition of 1,15,36,956 equity shares of Biocon Biologics from 127 selling shareholders, making BBL a wholly-owned subsidiary with effect from th...

Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale represent...

Why Is Concord Biotech Stock Up by 8% Today?

Synopsis: Concord Biotech Ltd shares jumped 8% after USFDA approval for its ANDA of Mycophenolate Mofetil oral suspension (200 mg/mL). The drug is an immunosuppressant for transpla...

MSCI Review On August 12: Laurus Labs, Biocon Emerge As Strongest Candidates

Among the likely beneficiaries, Laurus Labs and Biocon have been assigned a high probability of moving from the MSCI India Small Cap Index to the MSCI India Standard Index.

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

'GLP-1 alters...': Kiran Mazumdar-Shaw sounds caution as Nithin Kamath flags weak drug demand

Kamath believes affordability is no longer the biggest obstacle. According to him, convincing people to remain on a weekly injection indefinitely is proving to be a much harder pro...

Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal

Kiran Mazumdar-Shaw founded Immuneel Therapeutics raises Rs 100 Cr in Series B Funding

Immuneel Therapeutics will utilise the funding round for multiple initiatives that include expanding manufacturing capacity, R&D and international expansion.

NATCO Pharma Stock in Focus After Receiving USFDA Approval For Cancer Drug With Lupin

Synopsis: NATCO Pharma and its alliance partner Lupin have received USFDA approval for Eribulin Mesylate Injection, a generic version of Eisai’s Halaven used in the treatment of me...

Biocon founder Kiran Mazumdar-Shaw says India needs patient capital for Biotech

Biocon founder says India has the talent and scientific capability to build global biotech champions, but lacks the funding ecosystem needed to scale them

Sanstar Limited Announces Strategic Partnership with Ingredion Incorporated Through Preferential Issue and Joint Venture

Multibagger Ashish Kacholia Stock in Which DIIs Nearly Tripled Their Stake to Keep on Your Radar

Synopsis: Institutional investors nearly tripled their stake in a Himachal Pradesh-based oncology pharma company in a single quarter, even as the stock rallied sharply – a vote of...

Ipca inks licensing agreement with Bhami Research for biologics delivery platform access

Licencing agreement grants Ipca access to Bhami Research’s proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialisation of mult...

India’s lifesciences sector sees momentum build in innovation: BCG -HealthKois report

Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March 2026, and biotech startups grew from roughly 1,500 to 2,40...

Pharma Stock Jumps 10% After Securing Japanese Patent for Cancer Treatment Compound

Synopsis: Shares surged 10% after the company secured a Japanese patent for a novel cancer-treatment compound. The patent covers compounds effective against cancer and cancer stem...

Bliss GVS Pharma Rallies 45% in 10 Sessions Via The Anupam Rasayan Deal and Two Other Catalysts

Synopsis: A rare convergence of a Rs. 2,198 crore control-change acquisition by Anupam Rasayan India, a fresh WHO-GMP certification for its Palghar manufacturing unit, and a 129 pe...

Glenmark Pharma Share: How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?

Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs 19,000 crore AbbVie deal that could unl...

Anupam Rasayan in Focus After Acquiring Up to 48% Stake in Bliss GVS Pharma

Synopsis: Anupam Rasayan India Limited, a leading specialty chemicals company, announced on May 23, 2026, that it has signed a definitive agreement to acquire a 43.3% – 48.2% equit...

Q4 Results Today Live: IndiGo posts Q4 loss, RCOM loss widens, Natco Pharma & BEML Q4 profit down, Asian Paints &amp...

Q4 Results Highlights Today Live Updates: Stay tuned to businessline for the latest live updates on Q4 earnings.

Aspire Biopharma Issues Shareholder Letter

Shilpa Medicare Subsidiary Acquires 30.4% Stake Worth ₹63 Cr in Spanish Biotech Firm Gate2Brain

Synopsis: Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, will acquire a 30.4% stake in Spanish biotech company Gate2Brain for €7 million (around Rs. 63 crore). The p...

Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Divide...

NewsVoirNew Delhi [India], May 15: Akums Drugs & Pharmaceuticals Ltd., India's largest Contract Development and Manufacturing Organisation (CDMO), announced its financial resul...

Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Divide...

NewsVoirNew Delhi [India], May 15: Akums Drugs & Pharmaceuticals Ltd., India's largest Contract Development and Manufacturing Organisation (CDMO), announced its financial resul...